对于复发性卵巢癌的低分离短疗程放射治疗
Emily A Miller1, Amita Kulkarni1, Jeff F Lin1
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York Presbyterian, Hospital Weill Cornell Medicine, 525 E 68th St, New York, NY 10065, USA.
Gynecologic oncology reports
|January 26, 2026
概括
低分离辐射疗法 (HFRT) 对复发性卵巢癌具有前景,提供良好的反应率和最小毒性生存率. 这种方法对患有有限转移性疾病的患者尤其有益.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 妇科瘤学 妇科瘤学
背景情况:
- 化疗是前期卵巢癌的标准治疗,但放射治疗正在探索复发性疾病.
- 再发性卵巢癌带来了化学抵抗和治疗毒性等挑战.
- 低分离辐射疗法 (HFRT) 为每次治疗提供更高的剂量,可能更少的疗程.
研究的目的:
- 评估HFRT治疗的复发性卵巢癌患者的治疗反应和存活率.
- 在这个患者群体中评估HFRT的毒性概况.
主要方法:
- 在一个单一的学术机构进行回顾性队列研究.
- 从电子医疗记录中收集患者的人口统计数据,瘤特征和HFRT细节.
- 分析了治疗反应 (RECIST 1.1),存活率 (PFS,OS) 和毒性 (RTOG标准).
主要成果:
- 检查了22名患者,1例完全反应 (4.55%),8例部分反应 (36%),7例稳定疾病 (32%).
- 平均无进展生存期 (PFS) 为11.5个月;总生存期 (OS) 为28.7个月.
- HFRT耐受性良好,没有观察到3级或4级毒性.
结论:
- 对于精选的复发性卵巢癌患者来说,HFRT是一种可行的治疗选择.
- 对于患有寡头转移性疾病的患者来说特别有效.
- 高FRT扩大了在循环设置中的治疗选择.
相关概念视频
Cancer Therapies
9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies
8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.7K
Biological Effects of Radiation
17.7K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.7K
Radiation: Applications
1.7K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
The average...
1.7K
Absorption of Radiation
1.2K
The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
1.2K
Generating Electromagnetic Radiations
7.0K
The German physicist Heinrich Hertz (1857–1894) was the first to generate and detect certain types of electromagnetic waves in the laboratory. Starting in 1887, he performed a series of experiments that confirmed the existence of electromagnetic waves and verified that they travel at the speed of light. Hertz used an alternating-current RLC (resistor-inductor-capacitor) circuit that resonated at a known frequency and connected it to a loop of wire. High voltages induced across the gap in...
7.0K


